Skip to content

Achieving Portal Access With Scorpion Post-Approval Study (APASS)

A Prospective, Multicenter, Randomized Study Evaluating Portal Vein Access Sets During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedures

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05765253
Enrollment
3
Registered
2023-03-13
Start date
2023-07-13
Completion date
2023-11-19
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascites Hepatic, Hydrothorax, Liver Diseases, Portal Hypertension, Vascular Diseases

Keywords

Transjugular Intrahepatic Portosystemic Shunt, TIPS, Portal Vein Access

Brief summary

Creation of the parenchymal tract between the portal vein and the hepatic vein is the most difficult and time consuming step in a TIPS procedure. The purpose of this study is to evaluate portal vein access sets during the TIPS procedure.

Interventions

Portal Vein Access with Scorpion or Scorpion X set

DEVICECook Transjugular Liver Access Set

Portal Vein Access with Ring or Rosch-Uchida set

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Sponsors

Avania
CollaboratorINDUSTRY
Argon Medical Devices
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. ≥ 18 years of age at the time of the TIPS procedure 2. TIPS procedure initiated for refractory variceal bleeding, refractory ascites and/or hydrothorax 3. Willing and able to provide written informed consent and HIPAA (Health Insurance Portability and Accountability Act) authorization 4. Willing and able to comply with the study procedures and follow up schedule

Exclusion criteria

1. Known active malignancy 2. MELD score ≥ 18 at time of screening 3. History of polycystic liver disease 4. Active bleeding from any source 5. Pulmonary hypertension, heart failure, severe tricuspid valve dysfunction, right to left cardiopulmonary shunt 6. Chronic, occlusive portal vein thrombosis or complete portal vein thrombosis of the main or target portal vein on prior CT examination 7. Active or uncontrolled hepatic encephalopathy 8. Systemic infection/sepsis 9. Biliary obstruction 10. Uncorrectable coagulopathy 11. Any diminutive or partially thrombosed right portal vein 12. Hepatic vein thrombosis (i.e., no Budd-Chiari syndrome) 13. Known sensitivity to contrast or serious contrast reaction such as anaphylaxis 14. Pregnant women or women who are planning to become pregnant

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Procedural SuccessTIPS Procedure (Day 0), up to 93 minutesCreation of the parenchymal tract between the hepatic vein and an intrahepatic branch of the portal vein confirmed by portogram (CO2/contrast).
Composite of Major ComplicationsThrough 30 days post-TIPS procedureMajor complications associated with the procedure or study device and defined as complications resulting in an unplanned increase in the level of care, prolonged hospitalization, permanent adverse sequelae, or death.

Secondary

MeasureTime frameDescription
Number of Needle PassesTIPS Procedure (Day 0), up to 93 minutesCount of needle throws between the hepatic and portal vein to create the parenchymal tract.
Procedure DurationTIPS Procedure (Day 0), up to 93 minutesInterval (in minutes) from first jugular access for TIPS creation to removal of catheters from the patient.
Portal Vein Access (PVA) TimeTIPS Procedure (Day 0), up to 52 minutesTime (in minutes) from the first forward motion of the needle to confirmation of portal vein access via portogram.
Device-Related ComplicationsThrough 30 days post-TIPS procedureIncidence of complications related to the device as judged by the Investigator
Fluoroscopy TimeTIPS Procedure (Day 0), up to 31.5 minutesMeasured in minutes
Number of Participants With Technical SuccessTIPS Procedure (Day 0), up to 93 minutesCreation of a shunt (stent bridging) between the portal and systemic veins.

Countries

United States

Participant flow

Participants by arm

ArmCount
TIPS With Scorpion Portal Vein Access Kit
Scorpion or Scorpion X access set Scorpion Portal Vein Access Kit: Portal Vein Access with Scorpion or Scorpion X set Transjugular Intrahepatic Portosystemic Shunt (TIPS): Transjugular Intrahepatic Portosystemic Shunt (TIPS)
2
TIPS With Cook Transjugular Liver Access Set
Ring or Rosch-Uchida access set Cook Transjugular Liver Access Set: Portal Vein Access with Ring or Rosch-Uchida set Transjugular Intrahepatic Portosystemic Shunt (TIPS): Transjugular Intrahepatic Portosystemic Shunt (TIPS)
1
Total3

Baseline characteristics

CharacteristicTIPS With Scorpion Portal Vein Access KitTIPS With Cook Transjugular Liver Access SetTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants1 Participants2 Participants
Age, Categorical
Between 18 and 65 years
1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
1 Participants1 Participants2 Participants
Sex: Female, Male
Female
1 Participants1 Participants2 Participants
Sex: Female, Male
Male
1 Participants0 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 20 / 1
other
Total, other adverse events
2 / 21 / 1
serious
Total, serious adverse events
1 / 21 / 1

Outcome results

Primary

Composite of Major Complications

Major complications associated with the procedure or study device and defined as complications resulting in an unplanned increase in the level of care, prolonged hospitalization, permanent adverse sequelae, or death.

Time frame: Through 30 days post-TIPS procedure

ArmMeasureValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitComposite of Major Complications0 Events
TIPS With Cook Transjugular Liver Access SetComposite of Major Complications1 Events
Primary

Number of Participants With Procedural Success

Creation of the parenchymal tract between the hepatic vein and an intrahepatic branch of the portal vein confirmed by portogram (CO2/contrast).

Time frame: TIPS Procedure (Day 0), up to 93 minutes

Population: 2 participants with Scorpion Portal Vein Access Kit whereas 1 participant with Cook Transjugular Liver Access Set

ArmMeasureGroupValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitNumber of Participants With Procedural SuccessYes2 Participants
TIPS With Scorpion Portal Vein Access KitNumber of Participants With Procedural SuccessNo0 Participants
TIPS With Cook Transjugular Liver Access SetNumber of Participants With Procedural SuccessYes1 Participants
TIPS With Cook Transjugular Liver Access SetNumber of Participants With Procedural SuccessNo0 Participants
Secondary

Device-Related Complications

Incidence of complications related to the device as judged by the Investigator

Time frame: Through 30 days post-TIPS procedure

Population: 2 participants with Scorpion Portal Vein Access Kit whereas 1 participant with Cook Transjugular Liver Access Set

ArmMeasureGroupValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitDevice-Related ComplicationsSubject ID 02-0022 Number of AEs
TIPS With Scorpion Portal Vein Access KitDevice-Related ComplicationsSubject ID 02-0034 Number of AEs
TIPS With Cook Transjugular Liver Access SetDevice-Related ComplicationsSubject ID 02-0012 Number of AEs
Secondary

Fluoroscopy Time

Measured in minutes

Time frame: TIPS Procedure (Day 0), up to 31.5 minutes

Population: 2 participants with Scorpion Portal Vein Access Kit whereas 1 participant with Cook Transjugular Liver Access Set

ArmMeasureGroupValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitFluoroscopy TimeSubject ID 02-00218.2 Minutes
TIPS With Scorpion Portal Vein Access KitFluoroscopy TimeSubject ID 02-00316.7 Minutes
TIPS With Cook Transjugular Liver Access SetFluoroscopy TimeSubject ID 02-00131.5 Minutes
Secondary

Number of Needle Passes

Count of needle throws between the hepatic and portal vein to create the parenchymal tract.

Time frame: TIPS Procedure (Day 0), up to 93 minutes

Population: 2 participants with Scorpion Portal Vein Access Kit whereas 1 participant with Cook Transjugular Liver Access Set

ArmMeasureGroupValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitNumber of Needle PassesSubject ID 02-0021 Number of Needle Passes
TIPS With Scorpion Portal Vein Access KitNumber of Needle PassesSubject ID 02-0031 Number of Needle Passes
TIPS With Cook Transjugular Liver Access SetNumber of Needle PassesSubject ID 02-0013 Number of Needle Passes
Secondary

Number of Participants With Technical Success

Creation of a shunt (stent bridging) between the portal and systemic veins.

Time frame: TIPS Procedure (Day 0), up to 93 minutes

ArmMeasureGroupValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitNumber of Participants With Technical SuccessYes2 Participants
TIPS With Scorpion Portal Vein Access KitNumber of Participants With Technical SuccessNo0 Participants
TIPS With Cook Transjugular Liver Access SetNumber of Participants With Technical SuccessYes1 Participants
TIPS With Cook Transjugular Liver Access SetNumber of Participants With Technical SuccessNo0 Participants
Secondary

Portal Vein Access (PVA) Time

Time (in minutes) from the first forward motion of the needle to confirmation of portal vein access via portogram.

Time frame: TIPS Procedure (Day 0), up to 52 minutes

Population: 2 participants with Scorpion Portal Vein Access Kit whereas 1 participant with Cook Transjugular Liver Access Set

ArmMeasureGroupValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitPortal Vein Access (PVA) TimeSubject ID 02-0027 minutes
TIPS With Scorpion Portal Vein Access KitPortal Vein Access (PVA) TimeSubject ID 02-0038 minutes
TIPS With Cook Transjugular Liver Access SetPortal Vein Access (PVA) TimeSubject ID 02-00152 minutes
Secondary

Procedure Duration

Interval (in minutes) from first jugular access for TIPS creation to removal of catheters from the patient.

Time frame: TIPS Procedure (Day 0), up to 93 minutes

Population: 2 participants with Scorpion Portal Vein Access Kit whereas 1 participant with Cook Transjugular Liver Access Set

ArmMeasureGroupValue (NUMBER)
TIPS With Scorpion Portal Vein Access KitProcedure DurationSubject ID 02-00235 Minutes
TIPS With Scorpion Portal Vein Access KitProcedure DurationSubject ID 02-00349 Minutes
TIPS With Cook Transjugular Liver Access SetProcedure DurationSubject ID 02-00193 Minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026